Relationship Between the Effect of Roxadustat and Comorbid Diabetes in Non-dialyzed Chronic Kidney Disease Patients: A Retrospective Observational Study

Introduction The dose of roxadustat, a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, required to treat anemia, the hemoglobin level and the rate of hemoglobin target achievement were retrospectively investigated in non-dialyzed chronic kidney disease (CKD) patients with and without...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Hiroyuki, Araki, Rie, Mori, Toshiko, Inoue, Hideyuki, Matsumoto, Suzuko, Antoku, Shinichi, Yamasaki, Tomoko, Togane, Michiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290911/
https://www.ncbi.nlm.nih.gov/pubmed/37378104
http://dx.doi.org/10.7759/cureus.39543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290911/
https://www.ncbi.nlm.nih.gov/pubmed/37378104
http://dx.doi.org/10.7759/cureus.39543

Ejemplares similares